The present stock price for Navidea Biopharmaceuticals Inc. (NAVB) is $0.10. In the last trading session, the stock made a considerable jump, reaching $0.13 after an opening price of $0.11. The stock briefly fell to $0.10 before ending the session at $0.11.
In terms of market performance, Navidea Biopharmaceuticals Inc. had a fairly uneven. The highest value for the stock in the past year was $0.35 on 02/08/23, and the lowest value was recorded at $0.06 on 08/07/23.
Top 5 EV Tech Stocks to Buy for 2023
The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".
Click Here to Download the FREE Report.
Sponsored
52-week price history of NAVB Stock
A stock’s 52-week high and low prices can reveal much about its current status and future trajectory. Navidea Biopharmaceuticals Inc.’s current trading price is -72.11% away from its 52-week high, while its distance from the 52-week low is 55.91%. The stock’s price range during this period has spanned from $0.06 to $0.35. In the Healthcare sector, the Navidea Biopharmaceuticals Inc.’s shares surpassed a trading volume of approximately 3.69 million for the day, which was noticeably lower compared to the average daily volume of 9.7.56 million over the past three months.
Market Capitalization and Financial Performance: An In-Depth Look
Navidea Biopharmaceuticals Inc. (NAVB) has experienced a quarterly rise of 10.28% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 10.36M and boasts a workforce of 11 employees.
Making Sense of Trading Volume and Moving Average Data
Based on Barchart.com data, the company’s moving average over the 100-day period was 0.1068, with a change in price of -0.1525. Similarly, Navidea Biopharmaceuticals Inc. recorded 6,205,415 in trading volume during the last 100 days, posting a change of -61.00%.
NAVB Stock Stochastic Average
Today’s raw stochastic average for Navidea Biopharmaceuticals Inc. over the last 50 days is 42.35%.This indicates a increase from the raw stochastic average of the past 20 days, which was 33.75%. Moreover, the company’s Stochastic %K and %D values for the last 20 days were 51.37% and 64.59%, respectively.
NAVB Stock Price Performance Analysis
Investors’ outlook regarding the stock price performance over the year has been a mixed bag, with a range of optimism to pessimism depending on their perspective. The index has shown a price loss of -53.52% this year. Over the last six months, there has been a stronger performance of -70.42%. The price of NAVB fallen by 12.18% during the last 30 days period. For the last 5-days stocks have improved 5.40%.
